|
시장보고서
상품코드
1676625
세계의 정형외과용 성장 인자 시장 : 규모, 점유율, 동향 분석(2025-2031년) - MedCoreOrthopedic Growth Factor Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Cervical Disc Degeneration Market, Tibial Fracture Market, and 2 more |
||||||
세계의 정형외과용 성장 인자 시장 규모는 2024년에 10억 5,000만 달러에 달했습니다. 이 시장은 2.2%의 CAGR로 확대하며, 2031년에는 12억 달러에 달할 것으로 예측됩니다.
COVID-19 팬데믹에 의해 2020년에는 선택 수술 캔슬에 의한 판매 감소가 발생했습니다. 이러한 일시적인 혼란에도 불구하고 시장은 2022년까지 강력하게 회복되어 안정적인 성장세로 돌아섰습니다.
척추 고정술은 여전히 정형외과용 성장 인자 성장의 중요한 원동력입니다. 현재 진행 중인 임상 연구는 뼈 유합과 척추 치료에서 성장 인자의 효능을 입증하고 있습니다. 기업은 적응증 확대에 대한 FDA 승인을 받고 있으며, 이는 정형외과용 성장 인자의 폭넓은 채택으로 이어지고 있습니다. 최근 승인은 경추 추간판 변성증과 하지/족관절 고정술 분야의 성장에 박차를 가하고 있습니다.
세계의 정형외과용 성장 인자 시장에 대해 조사했으며, 시장의 개요와 시장 분석과 예측, 촉진요인과 억제요인, 경쟁 구도 등을 제공하고 있습니다.
목차
개요
- 세계의 정형외과용 성장 인자 시장 개요
- 경쟁 분석
- 시장 세분화
- 대상 지역
서론
시술 건수
시장 분석과 예측
건수 분석
- 경추 추간판 변성 성장 인자
- 경골 골절 정형외과용 성장 인자
- 척추 정형외과 성장 인자
- 발목과 족후부 융합 성장 인자
촉진요인과 억제요인
경쟁 시장 점유율 분석
KSA 25.03.21The global orthopedic growth factor market was valued at $1.05 billion in 2024 and is projected to grow at a CAGR of 2.2%, reaching $1.2 billion by 2031.
This market is segmented by indication type, including:
- Cervical Disc Degeneration
- Tibial Fractures
- Spine
- Ankle & Hindfoot Fusion
Market Insights & Data Coverage
- Unit Sales & Average Selling Prices
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031
- Historical Data (2021-2023)
- Competitive Landscape, Mergers & Acquisitions
- Company Profiles & Product Portfolios
Market Trends
- Impact of COVID-19 on Market Growth:
* The COVID-19 pandemic led to a decline in sales due to canceled elective surgeries in 2020.
* Despite this temporary disruption, the market recovered strongly by 2022 and returned to steady growth.
- Continued Demand for Spinal Fusion Therapies:
* Spinal fusion remains a key driver of growth for orthopedic growth factors.
* Ongoing clinical research supports the efficacy of growth factors in bone healing and spinal procedures.
- Regulatory Approvals Expanding Market Reach:
* Companies are securing FDA approvals for expanded indications, leading to wider adoption of orthopedic growth factors.
* Recent approvals have fueled growth in the cervical disc degeneration and hindfoot/ankle fusion segments.
Market Share Insights
Top Competitors in the Global Orthopedic Growth Factor Market (2024):
1 Medtronic
* Market leader in the orthopedic growth factor segment.
* INFUSE(R) remains the gold standard for spinal fusion therapies.
2 Cerapedics
* Second-largest market share with its i-Factor(TM) product.
* Expanded FDA approval allows i-Factor(TM) to be used in single-level anterior cervical discectomy fusion (ACDF) with an allograft bone ring or fusion interbody device.
3 Stryker
* Third-largest competitor, known for its AUGMENT(R) product line.
* AUGMENT(R) is the first and only FDA-approved alternative to autograft for hindfoot and ankle arthrodesis.
Market Segmentation Summary
Cervical Disc Degeneration Market
- Growth factors aiding in cervical spine fusion procedures.
Tibial Fracture Market
- Orthopedic growth factors used in tibial fracture repair and bone healing.
Spine Market
- Key segment driven by spinal fusion procedures.
Ankle & Hindfoot Fusion Market
- Focus on bone regeneration and fusion techniques for foot and ankle disorders.
Global Research Scope
- Regions Covered:
* North America (U.S., Canada)
* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
* Western Europe (Germany, France, U.K., Spain, Italy)
* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
* Middle East (Saudi Arabia, UAE, Israel)
* Asia Pacific (China, Japan, India, South Korea, Australia)
* Africa (South Africa, Egypt, Nigeria, Kenya)
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Coverage
- Market Size, Market Shares
- Market Forecasts, Growth Rates
- Units Sold, Average Selling Prices
- Procedure Numbers
Qualitative Coverage
- COVID-19 Impact
- Market Growth Trends & Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles & Product Portfolios
- FDA Recalls, Disruptive Technologies
- Disease Overviews
Data Sources:
- Primary Interviews with Industry Leaders
- Government Physician Data & Regulatory Data
- Hospital Private Data
- Import & Export Data
- iData Research Internal Database
TABLE OF CONTENT
- 5.1 Executive Summary
- 5.1.1 Global Orthopedic Growth Factor Market Overview
- 5.1.2 Competitive Analysis
- 5.1.3 Procedure Segmentation
- 5.1.4 Market Segmentation
- 5.1.5 Regions Included
- 5.2 Introduction
- 5.3 Procedure Numbers
- 5.4 Market Analysis and Forecast
- 5.5 Unit Analysis
- 5.5.1 Cervical Disc Degeneration Growth Factor Units Sold
- 5.5.1 Tibial Fracture Orthopedic Growth Factor Units Sold
- 5.5.2 Spine Orthopedic Growth Factor Units Sold
- 5.5.3 Ankle & Hindfoot Fusion Growth Factor Units Sold
- 5.6 Drivers and Limiters
- 5.6.1 Market Drivers
- 5.6.2 Market Limiters
- 5.7 Competitive Market Share Analysis
